European Basic Pharmaceutical Products Number of Enterprises Share by Country (Units (Enterprises))

The United Kingdom leads the European market for basic pharmaceutical enterprises with an 18.56% share, reflecting a modest 2.08% year-on-year increase. Belgium shows a robust growth trend with a 46.76% rise. Other notable increases include Portugal’s 21.29% and Estonia’s 14.87%. However, countries like France experienced a significant decrease at -9.1%. Over the past five years, we observe a stable but varied growth across countries, with Belgium and Portugal notably outperforming the average growth rates.

Future outlooks suggest potential shifts influenced by policy changes and healthcare infrastructure developments in key markets. Watch for increased consolidation in mature markets like Germany and Italy, while emerging markets may see new enterprise entries, particularly in Belgium and Eastern Europe.